Omeros

About:

Omeros is a clinical-stage biopharmaceutical company developing products focused on inflammation and central nervous system disorders.

Website: http://www.omeros.com

Twitter/X: omeroscorp

Top Investors: ARCH Venture Partners, MidCap Financial, National Institute on Drug Abuse (NIDA), Michael J. Fox Foundation, WRF Capital

Description:

Omeros is a Seattle-based commercial-stage biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, complement-mediated diseases and disorders of the central nervous system.